These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 26707683)
1. Effects of Alcohol Consumption on Hepatocarcinogenesis in Japanese Patients With Fatty Liver Disease. Kawamura Y; Arase Y; Ikeda K; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Inao M; Mochida S; Kumada H Clin Gastroenterol Hepatol; 2016 Apr; 14(4):597-605. PubMed ID: 26707683 [TBL] [Abstract][Full Text] [Related]
2. Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma. Kawamura Y; Arase Y; Ikeda K; Seko Y; Imai N; Hosaka T; Kobayashi M; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ohmoto Y; Amakawa K; Tsuji H; Kumada H Am J Gastroenterol; 2012 Feb; 107(2):253-61. PubMed ID: 22008893 [TBL] [Abstract][Full Text] [Related]
3. Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis. Kimura T; Tanaka N; Fujimori N; Sugiura A; Yamazaki T; Joshita S; Komatsu M; Umemura T; Matsumoto A; Tanaka E World J Gastroenterol; 2018 Apr; 24(13):1440-1450. PubMed ID: 29632425 [TBL] [Abstract][Full Text] [Related]
4. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. Inoue M; Yoshimi I; Sobue T; Tsugane S; J Natl Cancer Inst; 2005 Feb; 97(4):293-300. PubMed ID: 15713964 [TBL] [Abstract][Full Text] [Related]
5. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604 [TBL] [Abstract][Full Text] [Related]
6. Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index. Suh B; Yun JM; Park S; Shin DW; Lee TH; Yang HK; Ahn E; Lee H; Park JH; Cho B Cancer; 2015 Nov; 121(21):3818-25. PubMed ID: 26178294 [TBL] [Abstract][Full Text] [Related]
7. Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease. Ochiai Y; Kawamura Y; Kobayashi M; Shindoh J; Kobayashi Y; Okubo S; Muraishi N; Kajiwara A; Iritani S; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Kumada H Hepatol Res; 2021 Jan; 51(1):62-68. PubMed ID: 32939922 [TBL] [Abstract][Full Text] [Related]
9. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Ohki T; Tateishi R; Sato T; Masuzaki R; Imamura J; Goto T; Yamashiki N; Yoshida H; Kanai F; Kato N; Shiina S; Yoshida H; Kawabe T; Omata M Clin Gastroenterol Hepatol; 2008 Apr; 6(4):459-64. PubMed ID: 18387499 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands. van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867 [TBL] [Abstract][Full Text] [Related]
11. Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan. Tokushige K; Hashimoto E; Kodama K J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():88-92. PubMed ID: 24251711 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421 [TBL] [Abstract][Full Text] [Related]
13. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690 [TBL] [Abstract][Full Text] [Related]
14. [Alcoholic liver diseases in Japan and modification by hepatitis virus]. Horie Y; Yamagishi Y; Ishii H Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919 [TBL] [Abstract][Full Text] [Related]
15. Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine. Lim YS; Han S; Heo NY; Shim JH; Lee HC; Suh DJ Gastroenterology; 2014 Jul; 147(1):152-61. PubMed ID: 24583062 [TBL] [Abstract][Full Text] [Related]
16. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study. Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328 [TBL] [Abstract][Full Text] [Related]
17. National survey of hepatocellular carcinoma in heavy drinkers in Japan. Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504 [TBL] [Abstract][Full Text] [Related]
18. Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis. Kim SS; Hwang JC; Lim SG; Ahn SJ; Cheong JY; Cho SW Am J Gastroenterol; 2014 Aug; 109(8):1223-33. PubMed ID: 24890440 [TBL] [Abstract][Full Text] [Related]
19. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis. Aizawa Y; Shibamoto Y; Takagi I; Zeniya M; Toda G Cancer; 2000 Jul; 89(1):53-9. PubMed ID: 10897000 [TBL] [Abstract][Full Text] [Related]
20. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. Lin CW; Lin CC; Mo LR; Chang CY; Perng DS; Hsu CC; Lo GH; Chen YS; Yen YC; Hu JT; Yu ML; Lee PH; Lin JT; Yang SS J Hepatol; 2013 Apr; 58(4):730-5. PubMed ID: 23220252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]